94 related articles for article (PubMed ID: 10826518)
1. A novel bioassay for anti-thyrotrophin receptor autoantibodies detects both thyroid-blocking and stimulating activity.
Li Y; Kim J; Diana T; Klasen R; Olivo PD; Kahaly GJ
Clin Exp Immunol; 2013 Sep; 173(3):390-7. PubMed ID: 23647395
[TBL] [Abstract][Full Text] [Related]
2. Practical applications of studies on the TSH receptor and TSH receptor autoantibodies.
Furmaniak J; Sanders J; Sanders P; Miller-Gallacher J; Ryder MM; Rees Smith B
Endocrine; 2020 May; 68(2):261-264. PubMed ID: 32472423
[TBL] [Abstract][Full Text] [Related]
3. Development and basic performance verification of a rapid homogeneous bioassay for agonistic antibodies against the thyroid-stimulating hormone receptor.
Hoshina M; Ojima S; Kawasaki A; Doi K; Ohta S; Inoue A; Murayama H
J Immunol Methods; 2024 May; 528():113655. PubMed ID: 38447802
[TBL] [Abstract][Full Text] [Related]
4. Novel Antimurine Thyroid-Stimulating Hormone Receptor Monoclonal Antibodies.
Klee AN; Torchia JA; Freeman GJ
Monoclon Antib Immunodiagn Immunother; 2023 Jun; 42(3):109-114. PubMed ID: 37343169
[TBL] [Abstract][Full Text] [Related]
5. Minor hyperthyroidism with normal levels of thyroid-stimulating hormone receptor antibodies: a case report.
Ushakov AV
J Med Life; 2024 Feb; 17(2):236-238. PubMed ID: 38813368
[TBL] [Abstract][Full Text] [Related]
6. Autoantibody mimicry of hormone action at the thyrotropin receptor.
Faust B; Billesbølle CB; Suomivuori CM; Singh I; Zhang K; Hoppe N; Pinto AFM; Diedrich JK; Muftuoglu Y; Szkudlinski MW; Saghatelian A; Dror RO; Cheng Y; Manglik A
Nature; 2022 Sep; 609(7928):846-853. PubMed ID: 35940205
[TBL] [Abstract][Full Text] [Related]
7. Thyrotropin receptor autoantibody (TRAb) enhance the expression of thyrotropin receptor on mouse brain vascular endothelial cells: in vivo and in vitro.
Liang C; Yang H; Huang X; Kuang Y; Deng X; Liu Y; Luo Z
Cell Mol Biol (Noisy-le-grand); 2023 Sep; 69(9):67-74. PubMed ID: 37807332
[TBL] [Abstract][Full Text] [Related]
8. Changes of serum angiotensin-converting enzyme activity during treatment of patients with Graves' disease.
Lee DS; Chung JK; Cho BY; Koh CS; Lee M
Korean J Intern Med; 1986 Jan; 1(1):104-12. PubMed ID: 15759385
[TBL] [Abstract][Full Text] [Related]
9. Structure of full-length TSH receptor in complex with antibody K1-70™.
Núñez Miguel R; Sanders P; Allen L; Evans M; Holly M; Johnson W; Sullivan A; Sanders J; Furmaniak J; Rees Smith B
J Mol Endocrinol; 2023 Jan; 70(1):. PubMed ID: 36069797
[TBL] [Abstract][Full Text] [Related]
10. Characterization of Apparently Paradoxical Thyrotropin Binding Inhibitory Immunoglobulins With Neutral Bioactivity.
Tagami T; Moriyama K
J Endocr Soc; 2022 Jul; 6(7):bvac070. PubMed ID: 35611323
[TBL] [Abstract][Full Text] [Related]
11. Autoimmunity to the Follicle-Stimulating Hormone Receptor (FSHR) and Luteinizing Hormone Receptor (LHR) in Polycystic Ovarian Syndrome.
Schniewind HA; Sattler LM; Haudum CW; Münzker J; Minich WB; Obermayer-Pietsch B; Schomburg L
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34948471
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic Targeting of the IGF Axis.
Osher E; Macaulay VM
Cells; 2019 Aug; 8(8):. PubMed ID: 31416218
[TBL] [Abstract][Full Text] [Related]
13. Usefulness of TSH receptor antibodies as biomarkers for Graves' ophthalmopathy: a systematic review.
Seo S; Sánchez Robledo M
J Endocrinol Invest; 2018 Dec; 41(12):1457-1468. PubMed ID: 30194634
[TBL] [Abstract][Full Text] [Related]
14. Second degree AV block and severely impaired contractility in cardiac myxedema: a case report.
Chatzitomaris A; Scheeler M; Gotzmann M; Köditz R; Schildroth J; Knyhala KM; Nicolas V; Heyer C; Mügge A; Klein HH; Dietrich JW
Thyroid Res; 2015; 8():6. PubMed ID: 26000037
[TBL] [Abstract][Full Text] [Related]
15. Delineating the autoimmune mechanisms in Graves' disease.
Morshed SA; Latif R; Davies TF
Immunol Res; 2012 Dec; 54(1-3):191-203. PubMed ID: 22434518
[TBL] [Abstract][Full Text] [Related]
16. Neutral antibodies to the TSH receptor are present in Graves' disease and regulate selective signaling cascades.
Morshed SA; Ando T; Latif R; Davies TF
Endocrinology; 2010 Nov; 151(11):5537-49. PubMed ID: 20844004
[TBL] [Abstract][Full Text] [Related]
17. Characterization of thyrotropin receptor antibody-induced signaling cascades.
Morshed SA; Latif R; Davies TF
Endocrinology; 2009 Jan; 150(1):519-29. PubMed ID: 18719020
[TBL] [Abstract][Full Text] [Related]
18. Detection of functionally different types of pathological autoantibodies against thyrotropin receptor in Graves' patients sera by luminescent immunoprecipitation analysis.
Minich WB; Loos U
Exp Clin Endocrinol Diabetes; 2000; 108(2):110-9. PubMed ID: 10826518
[TBL] [Abstract][Full Text] [Related]
19. Immunoprecipitation analysis of pathological autoantibodies in Graves' patients' sera using biotinylated human thyrotropin receptor labeled with 125I-neutravidiny.
Minich WB; Weymayer JD; Loos U
Exp Clin Endocrinol Diabetes; 1999; 107(8):555-60. PubMed ID: 10612487
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
